Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
368 participants
INTERVENTIONAL
2014-12-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dario™ Blood Glucose Monitoring System - User Performance Evaluation
NCT02053584
Dario Blood Glucose Monitoring System - Android Devices User Performance Study Report
NCT02910674
Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude
NCT02352298
Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study
NCT02916563
Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System
NCT02041286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dario Blood Glucose Monitoring System
Subject will be requested to follow the device instructions and perform his/her own finger-stick test using the Dario Glucose Monitoring System (BGMS).
Dario Blood Glucose Monitoring System
Finger-stick obtained with BGMS
YSI
Finger-stick sample obtained by nurse/technician to be tested with YSI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dario Blood Glucose Monitoring System
Finger-stick obtained with BGMS
YSI
Finger-stick sample obtained by nurse/technician to be tested with YSI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject speaks and reads English proficiently
3. Subjects owns and uses Android and iOS based smart mobile device for at least 1 year
4. Subject is able and agrees to sign the informed consent form (minor subjects must be accompanied by a parent or legal guardian to provide consent for their participation in the study).
Exclusion Criteria
2. Subject is critically ill
3. Subject has an impairment that prevents him/her to follow the study procedures
4. Subject has any condition that the Principal Investigator believes may interfere in the subject's participation in the study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LabStyle Innovations Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Remington-Davis, Inc.
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.